trending Market Intelligence /marketintelligence/en/news-insights/trending/uposufntucy7he2w_uxizg2 content esgSubNav
In This List

Orgenesis raises $5M via placement of shares, warrants

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Orgenesis raises $5M via placement of shares, warrants

Orgenesis Inc. issued 798,803 common shares and warrants to buy 798,803 shares in a private placement.

The warrants have an exercise price of $6.24 each, and are valid for three years.

The company raised proceeds of about $5 million through the placement, which will go toward its global contract development and manufacturing organization network, as well as general corporate purposes.

Germantown, Md.-based Orgenesis develops technologies and provides services related to cell therapy and regenerative medicine.